Cargando…
Cross-linked hyaluronic acid gel occlusive device for the treatment of dry eye syndrome
PURPOSE: A new cross-linked hyaluronic acid (xlHA) gel occlusive device was assessed for safety and efficacy in the treatment of dry eyes. METHODS: This was an institutional review board-approved, single-site, open-label, prospective study to assess the efficacy and safety of placing the xlHA gel in...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231461/ https://www.ncbi.nlm.nih.gov/pubmed/30510396 http://dx.doi.org/10.2147/OPTH.S187963 |